Mucous membrane pemphigoid: A dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease

British Journal of Dermatology

Volumn 138, Issue 4, 1998, Pages 602-610

  Setterfield, J ^a   Shirlaw, P J ^b   Kerr Muir, M ^c   Neill, S ^a   Bhogal, B S ^a   Morgan, P ^b   Tilling, K ^c   Challacombe, S J ^b   Black, M M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE DISEASE; BLISTER; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PEMPHIGOID; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SKIN BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BASEMENT MEMBRANE; BIOLOGICAL MARKERS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 0031947636     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02168.x     Document Type: Article

References (29)

1. Lever WF. Pemphigus and Pemphigoid. Springfield, IL: Charles C Thomas, 1965.
2. Bean SF. Cicatricial pemphigoid. Immunofluorescent studies. Arch Dermatol 1974; 110: 552-5.
3. Anhalt GJ. Pemphigoid: bullous and cicatricial. Dermatol Clin 1990; 8: 701-16.
4. Frith PA, Venning VA, Wojnarowska F et al. Conjunctival involvement in cicatricial and bullous pemphigoid: a clinical and immunopathological study. Br J Ophthalmol 1989; 73: 52-6.
5. Domloge-Hultsch N, Gammon WR, Briggaman RA et al. Epiligrin, the major human keratinocyte integrin ligand, is a target in both acquired and inherited subepidermal blistering skin disease. J Clin Invest 1992; 90: 1628-33.
6. Domloge-Hultsch Anhalt GJ, Gammon WR et al. Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol 1994; 130: 1521-9.
7. Michel B, Milner Y, David K. Preservation of tissue-fixed immunoglobulins in skin biopsies of patients with lupus erythematosus and bullous disease - preliminary report. J Invest Dermatol 1972; 59: 449-52.
8. Vaughan Jones SA, Palmer I, Bhogal BS et al. The use of Michel's transport medium for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases. J Cutan Pathol 1995: 22: 365-70.
9. Black MM, Bhogal BS. Diagnosis, diagnostic and research techniques. In: Management of Blistering Diseases (Briggaman RA, Wojnarowska F, eds). New York: Raven Press, 1990, 15-34.
10. Woodley D, Saunder D, Talley MJ et al. Localisation of basement membrane components after dermal-epidermal junction separation. J Invest Dermatol 1983: 81: 149-53.
11. Fine JD, Neises GR, Katz SI. Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid. J Invest Dermatol 1984; 82: 39-43.
12. Kelly SE, Wojnarowska F. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol 1988; 118: 31-40.
13. Sarret Y, Hall R, Cobo LM et al. Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies. J Am Acad Dermatol 1992; 24: 952-8.
14. Bernard P, Prost C, Lecerf V et al. Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol 1990: 94: 630-5.
15. Chan LS, Yancey KB, Hammerberg C et al. Immune-mediated subepithelial blistering diseases of the mucous membranes. Arch Dermatol 1993; 129: 445-8.
16. Axt M, Wever S, Baier G et al. Das vernarbende Pemphigoid- ein therapeutisches Problem. Hautarzt 1995; 46: 620-7.
17. Bernard P, Prost C, Durepaire N et al. The major cicatricial pemphigoid antigen is a 180kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen. J Invest Dermatol 1992; 99: 174-9.
18. Liu Z, Diaz LA, Troy AF et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid. using antibodies generated against the hemidesmosomal antigen. BP 180. J Clin Invest 1993; 92: 2480-8.
19. Liu Z, Giudice GJ, Swartz SJ et al. The role of complement in experimental bullous pemphigoid. J Clin Invest 1995; 95: 1539-44.
20. Smith EP, Taylor TB, Meyer LJ, Zone JJ. Identification of a basement membrane zone antigen reactive with circulating IgA antibodies in ocular cicatricial pemphigoid. J Invest Dermatol 1993; 101: 619-23.
21. Allen J, Zhou H, Zhou S, et al. Cicatricial pemphigoid: Immunoblotting demonstrates that individual patients target multiple antigens. Br J Dermatol 1997; 136: 451 (Abstr).
22. Hashimoto T, Han-Yaku H, Higashiyama M et al. Four Japanese patients with cicatricial pemphigoid showing both IgG and IgA antibodies against the 180kDa bullous pemphigoid antigen. Br J Dermatol 1997: 137: 305-6.
23. Vanderlugt CJ, Miller SD. Epitope spreading. Curr Opin Immunol 1996; 8: 831-6.
24. Frank MM. The complement system in host defence and inflammation. Rev Infect Dis 1979: 1: 483-501.
25. Hiemstra PS, Gorter A, Stuurman ME et al. Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol 1987: 17: 521-6.
26. Russell MW, Mansa B. Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA. Scand J Immunol 1989; 30: 175-83.
27. Lamm ME, Nedrud JG, Kaetzel CS, Mazanec MB. IgA and mucosal defence. APMIS (Copenhagen) 1996: 103: 241-6.
28. Kaetzel CS, Robinson JK, Chintalacharuva KR et al. The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defence function for IgA. Proc Natl Acad Sci USA 1991; 88: 8796-800.
29. Grifliss JM, Goroff DK. IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms. J Immunol 1983; 130: 2882-5.